What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
V. Basile, S. Puglisi*, B. Altieri, L. Canu, R. Libe, F. Ceccato, F. Beuschlein, M. Quinkler, A. Calabrese, P. Perotti, P. Berchialla, U. Dischinger, F. Megerle, E. Baudin, I. Bourdeau, A. Lacroix, P. Loli, A. Berruti, D. Kastelan, H.R. HaakM. Fassnacht, M. Terzolo
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question'. Together they form a unique fingerprint.